课题基金 / 基金详情

Development of selective melanocortin receptor agonists and antagonists

Development of selective melanocortin receptor agonists and antagonists
选择性黑皮质素受体激动剂和拮抗剂的开发
批准号:
nhmrc : 1084604
负责人:
Dr Christina Schroeder
金额:
$45.65万
依托单位国家:
澳大利亚
项目类别:
Project Grants
财政年份:
2015
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2015-01-01 至 2017-12-31

项目摘要

项目成果

Dr Christina Schroeder的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Human melanocortin receptors play a key role in a variety of physiological processes ranging from energy regulation, skin pigmentation and regulation of food intake. This project aims to generate novel peptide based molecules that will selectively interact with different melanocortin receptors to better understand their pharmacology thereby opening the potential for future drug development for obesity, stroke or inflammatory skin disorders.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The potential of membranes – peptide engineering to modulate ion channels
  • 批准号:
    FT160100055
  • 项目类别:
    ARC Future Fellowships
  • 资助金额:
    $38.49万
  • 财政年份:
    2017
  • 负责人:
    Dr Christina Schroeder
  • 依托单位:
Development of new anticancer drugs using sortase-mediated ligation
  • 批准号:
    nhmrc : 1047857
  • 项目类别:
    Project Grants
  • 资助金额:
    $41.23万
  • 财政年份:
    2013
  • 负责人:
    Dr Christina Schroeder
  • 依托单位:
Mechanism of interaction of VWC domains and consequence for protein function
  • 批准号:
    nhmrc : 568804
  • 项目类别:
    NHMRC Project Grants
  • 资助金额:
    $34.46万
  • 财政年份:
    2009
  • 负责人:
    Dr Christina Schroeder
  • 依托单位:
国内基金
海外基金
新型M4受体选择性拮抗剂的研究